The Evaluation of COVID-19 Vaccine Hesitancy Level in Pregnant Women

Authors : Burçin Bektaş Pardes, Mehmet Ferdi Kıncı, Berican Şahin Uyar, Firangiz Mirzazada, Begüm Köse, Ahmet Akın Sivaslıoğlu

Pages : 49-53

Doi:10.61399/ikcusbfd.1481463

View : 18 | Download : 17

Publication Date : 2025-01-31

Article Type : Research Paper

Abstract :Objective: The most common cause of COVID-19 vaccine hesitancy is fear of side effects and unknown long-term results. This study aimed to determine the COVID-19 vaccine instability level of pregnant women followed up in a training and research hospital in Turkiye. Material and Method: This prospective survey study was conducted in Mugla Sıtkı Kocman University (MSKU) Hospital pregnancy outpatient clinic between dates June- August 2022 through face-to-face interviews. Totally 380 pregnant women were included in the study. Research data were collected using the Sociodemographic Data Collection Form and the COVID-19 Vaccine Hesitancy Scale. Statistical significance level was accepted as p< 0.05. Results: The mean age of the pregnant women participating in the study was 26.05±10.22 and their mean gestational week was 24.20±12.30. The mean score of COVID-19 vaccine hesitancy scale was 15.85±6.44. The COVID-19 vaccine acceptance rate of pregnant women was found to be 76%. Conclusion: According to the results of our study, the COVID-19 vaccine hesitancy rate is low compared to the current literature. It is thought that the reason for the increase in the vaccine acceptance rate is the increase in the number of vaccinated pregnant women and the confidence that has arisen due to the lack of complications.
Keywords : COVID-19, gebelik, aşı kararsızlığı